Table 1.
Baseline characteristics across study groups.
| 25 h budget N = 39 | 40 h budget N = 38 | 55 h budget N = 39 | Statistical test of group differences | |
|---|---|---|---|---|
| Continuous variables | Mean (SD) | Mean (SD) | Mean (SD) | |
| Age (in years) | 40.8 (10.4) | 41.7 (10.4) | 41.3 (10.7) | F = 0.06, df = 2; p = 0.943 |
| Education (in years) | 11.8 (3.5) | 11.5 (3.2) | 10.9 (2.3) | F = 0.91, df = 2; p = 0.404 |
| GAF Score | 57.3 (10.5) | 56.7 (11.7) | 54.2 (13.79 | F = 0.73, df = 2; p = 0.486 |
| CGI Score | 4.8 (1.0) | 4.7 (1.4) | 5.1 (0.8) | F = 1.76, df = 2; p = 0.176 |
| Categorical variables | N (%) | N (%) | N (%) | |
| Female gender | 23 (59.0) | 19 (50.0) | 17 (43.6) | X2 = 1.86, df = 2; p = 0.394 |
| F1 diagnosis | 4 (10.3) | 3 (7.9) | 5 (12.8) | X2 = 0.50, df = 2; p = 0.777 |
| F2 diagnosis | 3 (7.7) | 4 (10.5) | 4 (10.3) | X2 = 0.22, df = 2; p = 0.895 |
| F3 diagnosis | 22 (56.4) | 15 (39.5) | 13 (33.3) | X2 = 4.54, df = 2; p = 0.103 |
| F4 diagnosis | 8 (20.5) | 9 (23.7) | 4 (10.3) | X2 = 2.57, df = 2; p = 0.277 |
| F6 diagnosis | 1 (2.6) | 6 (15.8) | 9 (23.1) | X2 = 7.09, df = 2; p = 0.029 |
GAF, Global Assessment of Functioning scale; CGI, Clinical Global Impressions scale; F1, Mental and behavioral disorders due to psychoactive substance use; F2, Schizophrenia, schizotypal, delusional, and other non-affective psychotic disorders; F3, Affective disorders; F4, Anxiety, dissociative, stress-related, somatoform and other non-psychotic mental disorders; F6, Disorders of adult personality and behavior.